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Abstract
In recent years, there has been accumulating evidence that microRNAs are key regulator molecules of gene expression. The
cellular processes that are regulated by microRNAs include e.g. cell proliferation, programmed cell death and cell
differentiation. Adipocyte differentiation is a highly regulated cellular process for which several important regulating factors
have been discovered, but still not all are known to fully understand the underlying mechanisms. In the present study, we
analyzed the expression of 597 microRNAs during the differentiation of mouse mesenchymal stem cells into terminally
differentiated adipocytes by real-time RT-PCR. In total, 66 miRNAs were differentially expressed in mesenchymal stem cell-
derived adipocytes compared to the undifferentiated progenitor cells. To further study the regulation of these 66 miRNAs in
white adipose tissue in vivo and their dependence on PPARc activity, mouse models of genetically or diet induced obesity
as well as a mouse line expressing a dominant negative PPARc mutant were employed.
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Introduction
During the last decades, obesity and associated diseases, such as
type 2 diabetes, hypertension, and cardiovascular disease, have
reached an epidemiologic proportion [1,2]. This fact has led to
intensive studies, conducted with the help of suitable cell culture
systems, supplemented by transgenic- or knock-out mouse models
to investigate the genetic or environmental factors influencing
obesity. The employment of such mouse models has revealed more
than 200 genes involved in the regulation of fat metabolism and
adiposity. These genes may affect the regulation of food uptake,
differentiation of preadipocytes, or fat storage capability of
adipocytes [3]. Although the role of many protein-encoding genes
has been well established, much less is known about the regulatory
influence of microRNAs (miRNAs) on proteins or gene-transcripts,
involved in these processes. microRNAs are defined as a class of
short interfering RNAs, which are capable to bind to partially
complementary sequences localized within the 39-untranslated
regions (39-UTRs) of mRNAs. miRNAs affect gene expression as
part of a multi-modal protein complex, called RNA Induced
Silencing Complex (RISC). Binding of miRNAs to target mRNAs
results in translational repression or degradation of the targeted
transcript. Cumulating evidence allocates miRNA functions to
integral parts of regulatory cellular processes, including the
differentiation of stem cell populations, the regulation of metabolic
activities, and tumorigenesis [4,5,6].
Multipotent adult mesenchymal stem cells (MSC) are capable of
differentiating into a variety of cell types, including adipocytes,
osteoblasts, chondrocytes, and myocytes [7,8,9]. Regulation of
stemcellness vs. differentiation is a key event in mesenchymal stem
cell biology, and allows appropriate tissue homeostasis, while
maintaining a sufficient pool of precursor cells for further use.
Such pools of mesenchymal stem cells, residing in the bone
marrow or the vascular stroma of adipose tissue, are also the
source for MSCs, which ultimately develop into adult adipocytes
[10,11,12]. In vitro, MSCs proliferate and develop into preadipo-
cytes after reaching confluency. Preadipocytes are still competent
for proliferation but, when allowed to become confluent and
treated with substances such as insulin and glucocorticoids, cease
cell division and differentiate into adipocytes, [13]. At the
molecular level, the core process of adipogenesis is regulated by
transcription factors, such as CCAAT/enhancer binding protein a
(C/EBP-a) and peroxisome proliferator activated receptor c
(PPARc), a heterodimerization partner of Retinoic X receptors
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transcription factors ultimately drives the expression of adipocyte
specific factors such as enzymes responsible for the synthesis and
storage of triglycerides in lipid droplets. [17,18].
Here, we describe the results of a miRNome-wide analysis of
primary adipocyte differentiation, conducted by a novel screening
strategy. By using pools of RNAs from MSCs at different time
points after adipocyte differentiation, we could reduce the
complexity of such a real-time PCR based screening approach
while keeping the detection sensitivity. Pools of 5 RNAs from
undifferentiated MSCs or differentiated cells at four different time
points were used for RT-PCR analysis in order to exclude those
miRNAs from further tests which were not present at detectable
levels in any of the samples. In a second step, detectable miRNA
species were investigated in individual RNA samples for their
expression patterns during in vitro differentiation of MSC.
Regulated miRNA candidates, revealed during the MSC screen,
were further studied in vivo using white fat tissue samples from
mouse models of genetically or diet induced obesity. Whether the
expression of these miRNAs was dependent on PPARc activity in
vivo was further analyzed in a mouse model harbouring a
dominant-negative PPARc mutation (P465L).
Materials and Methods
Cell culture
All cells were cultured in a 5% CO2 humified atmosphere at
37uC in T25-culture flasks. The culture media were changed every
second or third day. Mouse mesenchymal stem cells (MSC)
derived from bone marrow of 4 weeks old C57/Bl6 mice were a
kind gift from the group of Viktor Wixler, University of Mu ¨nster.
The cells were previously characterized as mesenchymal stem cells
by determination of surface marker genes using quantitative RT-
PCR and their potential to differentiate into osteogenic,
chondrogenic and adipogenic lineages [19]. The MSC were
cultivated in a mixture of 60% DMEM and 40% MCDB-201
medium (Sigma-Aldrich) supplemented with 2% FCS, 100 units
penicillin/ml, 100 mg/ml streptomycin, 10 ng/ml EGF and
10 ng/ml PDGF (R&D Systems), 1 mg/ml linoleic acid (Sigma-
Aldrich), 10 ng/ml leukemia inhibitory factor (LIF, Chemicon
International, Inc.), 5 mg/ml insulin-transferrin-selenium mixture
(Sigma-Aldrich), 0.1 mM ascorbate-2-phosphate and 10
22 mM
dexamethasone (DMX) (Sigma-Aldrich).
MSC were induced to differentiate at the third day after
reaching confluency by addition of differentiation medium (60%
DMEM, 40% MCDB-201, 2% FCS, 100 units penicillin/
ml,100 mg/ml streptomycin ,1 mg/ml linoleic acid, 0.1 mM
ascorbate-2-phosphate, 0.5 mM 3-isobutyl-1-methylxanthine
(IBMX), 1 mM DMX and 10 mg/ml insulin-transferrin-selenium
mixture). After three days the medium was changed to adipocyte
maintenance medium containing the same supplements as the
differentiation medium but with hundred fold lower DMX
concentration and lacking IBMX. The cells were cultivated for
additional 7 days. Total RNA including miRNA was isolated from
normal proliferating cells (as reference), as well as from confluent
cells at the day of induction (d0), and at two (d2), four (d4), seven
(d7) and ten (d10) days after induction using miRNeasy Mini Kit
according to the manufacturers protocol (QIAGEN). For verifi-
cation of the results, cells from two passages (passages number 5
and 8) were analyzed independently. For visualisation of the
differentiated adipocytes, the cells were stained with Oil Red O by
washing twice with PBS and fixing with 4% paraformaldehyde in
PBS at 4uC over night. The solution was removed and the fixed
cells were washed with 60% isopropanol. After drying, cells were
stained in fresh Oil Red O solution (60% Oil Red O stock,
consisting of 0.35% Oil Red O in isopropanol, and 40% H2O) for
at least one hour at room temperature. Subsequently, the cells
were washed several times with water.
NIH/3T3-cells (American Type Culture Collection, ATCC)
were cultivated in DMEM (Gibco) supplemented with 10% FCS
(BioChrom), 100 units penicillin/ml,100 mg/ml streptomycin and
non-essential amino acids (Invitrogen). After reaching confluency
(k0) the cells were cultivated for further three days (k1–k3) and total
RNA was isolated at every time point using miRNeasy Mini Kit
according to the manufacturer’s protocol (QIAGEN).
Mouse studies
Unless stated otherwise, mice were housed in a temperature-
controlled room (22uC) with a 12-hour light/dark cycle and had
free access to food and water. All animal protocols were approved
by the UK Home Office, licence number 80/2098 and the
University of Cambridge. The first model consisted of leptin-
deficient ob/ob mice on a C57BL/6 genetic background. ob/ob
mice were fed a standard laboratory chow diet (10% calories from
fat) and were compared to littermate wt control animals. The
second group of mice consisted of animals exposed to diet-induced
obesity. Mice on a mixed C57BL/6J/SV129 genetic background
were fed a high-fat diet (HFD) for 10 weeks from weaning (45%
calories from fat) and compared to littermate controls fed a chow
diet from weaning. The final experimental group was a mouse
model harbouring a dominant-negative PPARc mutation (P465L)
fed either a chow diet or HFD. Leptin-deficient ob/ob mice and
litter mate controls were purchased from Harlan (Harlan, UK).
Animals for the HFD studies and P465L DN mice were bred in-
house at Cambridge University. For every model the epididymal
fat pads of five 10–13 weeks old male mice were harvested, frozen
in liquid nitrogen and stored at 280uC. Total RNA including
miRNAs of all tissue samples were extracted using miRNeasy Mini
Kit (QIAGEN) according to the manufacturer’s protocol and the
TissueRuptor (QIAGEN) for homogenisation.
Quantitative real-time PCR
For mRNA analyses 100 ng total RNA were reverse-transcribed
by Omniscript RT Kit (QIAGEN). For real-time PCR amplifica-
tion QuantiTect SYBR Green PCR Kit and QuantiTect Primer
Assays were used according to manufacturer’s protocol (QIA-
GEN). GAPDH was used as endogenous control.
For miRNA analyzes 100 ng total RNA were reverse-tran-
scribed and amplified in real-time PCR using miScript-System
including miScript RT-Kit, miScript SYBR-Green PCR-Kit and
miScript Primer Assay miRBase v12 (QIAGEN) according to the
manufacturer’s protocol. For internal control the expression of the
small nuclear RNAs RNU1A, RNU6B and RNU5A as well as the
expression of the small nucleolar RNAs SNORA73A, SNORD25,
and SCARNA17 was determined. All PCR reactions were
performed in triplicate in 384-well plates and measured by ABI
7900HT (Applied Biosystems). Mean values and standard
deviations were calculated and fold changes were determined
using the DDCT method. miRNAs displaying a fold change .2o r
,0.5 during adipogenesis of mesenchymal stem cells or a fold
change .1.5 or ,0.66 in the in vivo obesity models in combination
with p-values,0.05 were regarded as regulated. During the
melting curve analysis after completion of the PCR amplification
cycles, the temperature is increased slowly from 65uCt o9 5 uC. At
low temperatures all PCR products are double stranded and
SYBR Green intercalates into these molecules leading to a high
fluorescence signal. Whereas at high temperatures, PCR products
are denatured, resulting in rapidly decreasing fluorescence signals.
Genome-Wide Profiling of MicroRNAs
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rises and plotted against temperature. A curve is produced, as the
fluorescence decreases slightly in the lower temperature range, but
decreases much more rapidly at higher temperatures when the
melting temperatures (Tm) of specific and nonspecific PCR
products are reached. The detection system calculates the first
derivatives of these curves, resulting in plots peaking at the
respective specific melting temperature of this PCR product (Tm).
These Tms may be used to check the specificity of the resulting
PCR products.
Agarose gel electrophoresis
After real-time PCR, the samples were analyzed by 2% agarose
gel electrophoresis containing 0.3 mg/ml ethidium bromide at
100 V for 1 h in order to identify the amplicon sizes of the PCR
products. As molecular weight marker the GenPilot 50 bp Ladder
(QIAGEN) was used.
Statistical analysis
For the statistical analysis of the expression data the student’s t
test was performed and p-values were calculated using the
unpaired two-tails method in Excel (Microsoft). Fold changes
with p-values,0.05 were considered to be statistically significant,
and fold changes with p-values,0.01 to be highly significant. For
the P465L DN mouse study results were analysed by two-way
ANOVA using SPSS 17.0 (IBM, New York). Data were
considered to be significant if there was either an effect of diet
or genotype or if a diet*genotype interaction with a p-value,0.05
was observed. For the analysis of the 66 miRNAs we corrected for
False Discovery Rate was corrected for using q statistics calculated
using R (R Foundation). P values were accepted as valid if the Q
statistic was less than P=0.05.
Results
Adipocyte-differentiation of murine mesenchymal stem
cells
For this study, bone marrow-derived murine mesenchymal stem
cells from 4 week-old C57BL/6 mice, that have been prepared by
depletion of CD45-expressing cells and that have been shown to
express CD34, c-kit, sca1 and CD13 [19], were used as the
adipogenesis model. Adipogenic differentiation was induced as
illustrated in Fig. 1A. Briefly, cells were cultivated until they
reached confluency. Then cells were grown for an additional three
days to induce growth arrest and subsequently the normal culture
medium was changed to adipocyte differentiation medium (day 0).
After cultivating the cells for further three days medium was
changed to maintenance medium (at day 3) which subsequently
was renewed every two days. Samples were taken from
subconfluent cell culture (as a reference), at day 0, and 2, 4, 7
and 10 days after induction of adipocyte differentiation. The
differentiation progress of two independent cell batches (referred
to as passage 5 and passage 8) was monitored by measuring the
induction of the adipocyte-differentiation markers adiponectin
(Adipoq), CD36 and PPARc by real-time PCR (compare Fig. 1B).
All three markers were up regulated in both cell passages upon
differentiation with highest expression levels between day 7 and 10
after differentiation. In parallel, adipocyte-differentiation could be
detected by visual inspection of the cell cultures. While
undifferentiated cells showed a flat and fibroblast-like shape
(Fig. 1C), cells became more and more rounded during the
differentiation process. In parallel, the formation of multilocular
lipid droplets in the cytoplasm could be observed in differentiating
adipocytes which became bigger during this process (compare
Fig. 1D). These vesicles could specifically be stained with Oil Red
O which was a further proof of the successful adipocyte
differentiation (data not shown). Cells from both passages showed
slightly different kinetics of adipogenesis; while cells from passage 5
were terminally differentiated at day 7 after induction, cells from
passage 8 differentiated slightly slower and reached this stage at
day 10 after initiation of adipocyte differentiation. This was
reflected both by the expression pattern of adipocyte marker genes
as well as by the morphology of the cells. Because of this obvious
difference between both cell passages, we included day 10 of
passage 8 in the following analyses whereas for passage 5, day 7
was the last time point that was included in the following miRNA
expression profiling.
Screening of miRNA expression in MSC-derived
differentiated adipocytes
A PCR-based approach employing miRNA-specific primers for
all known mouse microRNAs (583 in miRBase v.12) was used to
profile the expression of these molecules during adipogenesis. In
an initial screening, we used pools of five RNA samples from
passage 5 to get first information about the overall expression of
the complete miRNome that could be detected in these cells. For
this purpose, we pooled RNA from undifferentiated proliferating
MSC (as reference), and from cells of days 0, 2, 4 and 7 after
initiation of adipogenesis. This procedure (as depicted in Fig. 2A)
allowed us to quickly sort out miRNAs not being expressed in any
of the samples irrespective of their differentiation status. By using
this pooling approach, we found that 296 of all miRNAs were
absent in the pooled samples (CTso f.35), and that 36 miRNAs
were only weakly expressed (CT values between 30 and 35). 221
miRNAs showed an average expression level (CTs between 20 and
30) and 30 miRNAs displayed high expression levels with CT
values less than 20 (Fig. 2B). The specificity of the amplified PCR-
products was assessed by melting curve analysis. Because of the
largely uniform nature of the miRNA-specific PCR amplicons
(compare Fig. 2C), the expected Tm for true positive PCR
products should be 75uC( +/2 2uC). The specificity of most
miRNA PCR assays leading to detectable CT values could
therefore be confirmed by analyzing their respective melting
curves. As shown in Fig. 2D and 2E, specific PCR products with
melting temperatures of about 75uC did also posses the expected
size of 85 bp demonstrated by agarose gel electrophoresis (a
representative result for mir-30a is given). Thus, unspecific PCR
products displaying high Tm values could be easily identified by
melting curve analysis. Melting temperatures of about 80uCo r
higher indicate that the PCR product is most likely unspecific. In
this rare event, subsequent gel analysis revealed single or multiple
PCR products of the wrong size. The two examples shown here
are miR-21* displaying a melting curve peak at 79uC and multiple
PCR products ranging in size between 80 and 300 bp and miR-
125a-3p exhibiting a Tm of 80uC and one distinct PCR product of
about 230 bp (see Fig. 2D and 2E). Such microRNA PCR assays
giving rise to PCR products not passing the quality criteria
described here were subsequently excluded form further analysis.
For appropriate normalization of the miRNA expression values,
we intended to identify an endogenous small housekeeper
transcript showing low expression variation during adipogenesis.
For this purpose, we separately analyzed the expression of the six
small RNAs SNORA73A, SNORD25, SCARNA17, RNU6B,
RNU5A and RNU1A in all samples taken during the differenti-
ation of both MSC passages 5 and 8. These small transcripts are
highly suitable candidate RNAs for normalization of miRNA
expression levels because they are ubiquitously expressed, have
small sequence lengths of 45–200 bp and are, like mature
Genome-Wide Profiling of MicroRNAs
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standard deviation of all time-course samples were determined for
both cell passages (Fig. 2F shows the standard deviation of the CT
-values as a measure of the expression variation during the
differentiation time course). The small non-coding RNAs showing
the smallest variation of expression in both cell passages were
snoRNA73A and RNU1A. We selected SNORA73A exhibiting a
standard deviation of 0.12 and 0.18 respectively and not RNU1A
because the latter displayed less consistent amplification plots (data
not shown).
The expression patterns of the 287 miRNAs, that were
detectably expressed in the pooled samples, were reanalyzed in
both cell passages and for each individual sample of the MSC
differentiation time course. We found a total number of 66
Figure 1. Differentiation of mesenchymal stem cells to adipocytes. A: Protocol for the differentiation of mesenchymal stem cells to
adipocytes. B: Real-time PCR-based expression analysis of the adipocyte marker genes adiponectin (Adipoq), CD36 and PPARc during adipogenesis of
murine mesenchymal stem cells. For verification two cell passages (ip 5 and ip 8) were independently differentiated and analyzed. Data were
normalized by GAPDH expression and plotted as fold change (log10 scale) relative to the expression levels of the undifferentiated subconfluent
reference cells. C, D: Phenotypical change from fibroblast-like murine mesenchymal stem cells (C, 1006magnification) to round-shaped adipocytes
(D, 406magnification).
doi:10.1371/journal.pone.0021305.g001
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dividing cells with differentiated adipocytes in both cell replicates
(including days d0, d2, d4, and d7 in the case of passage 5 and
d0, d2, d4, d7 and d10 for passage 8) with fold changes higher
than 2 or less than 0.5. The individual expression data for each of
the 66 differentially regulated miRNAs is listed in supporting
table S1. Of these, 56 miRNAs were upregulated during
adipogenesis whereas ten of them showed reduced expression in
differentiated cells. Members of 5 miRNA families were
coordinately up regulated during adipogenesis, namely let-7a,
let-7c, let7-e, let-7g, and let-7i; members of the miR-29 family
miR-29a, miR-29b, and miR-29c; miR-30a_1, miR-30b, miR-
30c, miR-30d, and miR-30e; miR-181a, and miR-181b; miR-
199a, miR-199a-3p, miR199-b*. Besides these, miR103/107 and
miR-143, were also found to be upregulated in the adipogenesis
model analyzed here. Fig. 3 is showing the representative
expression kinetics for four upregulated and three down regulated
miRNAs in both cell passages.
Analysis of miRNAs regulated early after induction of
adipogenesis
The differentiation of mesenchymal stem cells into adipocytes
requires two steps, cell cycle arrest and treatment with
differentiating agents (IBMX, DMX). To identify the miRNAs
that have been up- or down-regulated because of the growth
arrest of the MSCs, confluent non-dividing NIH/3T3 mouse
fibroblasts, which are not capable of differentiating into
adipocytes, were tested as well. Cell counting of two individual
cell passages (passage 39 and passage 43) revealed that cells
stopped dividing one day after reaching confluency (Fig. 4A). The
expression of the 66 microRNAs being regulated during
adipogenesis of mesenchymal stem cells was also determined
from growth arrested NIH/3T3 cells at four different time points
(k0–k3) and compared to a reference of subconfluent dividing
NIH/3T3 cells. In MSCs, some miRNAs were differentially
regulated in both cell passages early after IBMX, DMX
treatment with fold-changes .2 at day 2 after induction (e.g.
miR-455; Fig. 3). In the confluent NIH/3T3 cells, only a small
number of miRNAs was up- or down-regulated more than two-
fold, five miRNAs showed induction of expression in both
passages, three miRNAs were down-regulated at confluency
(Fig. 4B). Five of these eight miRNAs (miR-199a, miR-7, miR-
146b, miR-7b, and miR-199b*) were similarly regulated early
during the adipogenesis process of MSCs, indicating that their
regulation was due to cell cycle arrest rather than adipogenesis.
Whereas miR-411 and miR-703 were regulated late during the
adipocyte differentiation process and miR-129-3p was up-
regulated in growth-arrested NIH/3T3 cells but down-regulated
in MSCs, indicating that these three miRNAs play different roles
in NIH/3T3 cells and differentiating MSCs.
Figure 3. Expression kinetics of miRNAs being differentially regulated during differentiation of MSC to adipocytes. The expression of
miRNAs was analyzed by real-time PCR individually at all time points during the differentiation course and for two independent cell passages (5 and
8) to identify miRNAs being regulated during adipogenesis of murine mesenchymal stem cells. Data were normalized to SNORA73A and plotted as
relative miRNA expression levels compared to the level of undifferentiated subconfluent reference cells.
doi:10.1371/journal.pone.0021305.g003
Figure 2. Real-time PCR based profiling of miRNAs being differentially regulated during the course of MSC differentiation to
adipocytes. A: RT-PCR based pooling strategy to identify all miRNAs being expressed in any of the samples taken during the differentiation time-
course. B: Summary of the expression levels of 583 miRNAs analyzed with the pooling strategy. C: Schematic overview of a typical miRNA PCR
amplicon produced by SYBR Green based miScript PCR assays. PCR products are typically around 85 bp long and of these 20 bp resemble the
variable miRNA sequence while the remaining 60 bases contain the universal PCR primer binding site introduced during reverse transcription. D–E:
Melting curve analysis (D) in combination with agarose gel electrophoresis (E), Lane 1: miR-21*, lane 2: miR-125a-3p, lane 3: miR-30a PCR-products,
‘‘L’’: GelPilot 50 bp Ladder revealed the specificity of miRNA PCR products. F: Identification of the most suitable housekeeping gene for the
normalization of the miRNA expression data. For this purpose the expression of six small RNAs was analyzed at all time points and in both cell
passages. To identify the small RNA showing the lowest variation over the whole sample set the mean values and standard deviations of all time
points were calculated for every gene and cell passage. The table shows the standard deviations of these means.
doi:10.1371/journal.pone.0021305.g002
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To gain further insight into the role of the microRNAs that have
been found to be differentially expressed during adipocyte
differentiation of mesenchymal stem cells, we investigated the
transcription patterns of these miRNAs in white adipose tissue
derived from several in vivo model systems. As a model for genetic
obesity we used leptin-deficient ob/ob mice that were compared
with corresponding wt littermates. In the second model, obesity of
the animals was induced by high fat diet (as described in materials
and methods) and these mice were compared with littermates fed a
chow diet. The degree of obesity is displayed by the epididymal fat
pad weight of the corresponding animals (Fig. 5A). In ob/ob-mice,
the epididymal fat pad weight was 3.24 g, more than 15 fold
greater than that of the corresponding control animals (n=8 per
group). In the case of the diet induced obesity model, the fat pad
weight of HFD animals was 1.24 g, 4 fold greater than that of the
control group (n=6 per group). By comparing white fat tissue of
leptin-deficient ob/ob mice with the corresponding tissue from
wild type mice with the same genetic background (C57BL/6), we
found 20 miRNAs being differentially expressed (cutoff: 1.5-fold
up regulation and 0.66 fold down regulation; p,0.05). Of these 20
miRNAs three were up-regulated in ob/ob-mice whereas the
other 17 were down-regulated compared to wt animals. Student’s
Figure 4. Analysis of growth arrested NIH/3T3-cells to identify miRNAs regulated due to quiescence of cells. A: Cell numbers of two
passages of NIH/3T3-cells were counted at subconfluence, at the day of confluency and at the following three days to identify the time-point of
complete proliferation arrest. B: Expression kinetics of miRNAs during proliferation arrest of NIH/3T3 cells were determined by RT-PCR. Data were
normalized to SNORA73A and plotted as relative expression changes compared to subconfluent reference cells.
doi:10.1371/journal.pone.0021305.g004
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PLoS ONE | www.plosone.org 7 June 2011 | Volume 6 | Issue 6 | e21305Figure 5. Differential expression of miRNAs in epididymal fat pads from mouse models of genetically or diet induced obesity. A:
Epididymal fat pad weights were compared of obese ob/ob mice and wild-type controls (Ob/ob model) and of wt or PPARc DN mice fed either a
chow or a high-fat diet (DIO model). B: miRNA levels were analyzed in epididymal fat pads from five wild-type (WT) and five leptin-deficient ob/ob
mice by real-time-PCR. Data were normalized to SNORA73A expression. The relative expression levels compared to wild-type mice were plotted and
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miRNAs and highly significant changes (p,0.01) for 8 miRNAs
(Fig. 5B). Interestingly, we found that the majority of those
miRNAs (17/20) that were upregulated in differentiating adipo-
cytes were downregulated in the fat pads of obese mice and vice
versa. Only three miRNAs were consistently regulated in both
model systems with miR-155 being upregulated both in differen-
tiating adipocytes and in obese mice and miR-466a-3p as well as
miR-467 that were downregulated in both adipocytes and obese
mice.
Additionally, we investigated the influence of high fat diet and
PPARc activity on microRNA expression either separately or in
combination. For this purpose, animals with a mixed genetic
background harboring either the PPARc wild type gene (WT) or a
dominant-negative PPARc mutation (P465L DN) were fed either
a high fat diet or a chow diet. The levels of the 66 miRNAs being
differentially expressed during in vitro adipocyte development,
were also determined in epididymal fat pads of the four in vivo
conditions (wt+chow, wt+HFD, P465L+chow, P465L+HFD).
Compared to wt chow fed animals that served as a reference 21
miRNAs were differentially expressed in at least one of the other
three conditions (fold change .1.5 or ,0.66; p,0.05). Using 2-
way ANOVA, the influence of the genotype (a), diet (b) or an
interaction of both factors (c) on the miRNA expression was
assessed (compare Fig. 5C). For eleven of these regulated miRNAs,
the diet was the only factor responsible for altered expression levels
(‘‘b’’ in Fig. 5C). In all these cases, the miRNA expression was
induced after high fat diet in both the wild-type as well as PPARc
mutant animals. The high fat diet induced up-regulation of miR-
421, miR-702 and miR-703, in these mouse models was not
reflected in the mesenchymal stem cell model of adipogenesis as
these miRNAs were down-regulated during in vitro adipocyte
differentiation. The expression of miR-146b that was induced both
early after induction of mesenchymal stem cell differentiation as
well as after reaching a growth arrest in NIH/3T3 fibroblasts, was
also significantly up-regulated upon HFD-treatment in wild-type
mice as well as mutant animals. The expression of four miRNAs
was only dependent on the PPARc expression status of the
animals; miR-199, miR-455 and miR-1192 were upregulated in
mice with dominant-negative PPARc irrespective of the diet given
to the animals, the fourth, miR-592, was reduced in mutant
animals (‘‘a’’ in Fig. 5C). An interaction between genotype and
diet on miRNA expression was found in three cases: miR-7b, miR-
27a and miR-34a were up-regulated in wt animals receiving high
fat diet but not upregulated in P465L DN mice receiving HFD
(‘‘c’’ in Fig. 5C).
Discussion
Experimental strategy for miRNA profiling
In the present study, we have analyzed the expression pattern of
583 mouse miRNAs during the adipogenic differentiation of
murine mesenchymal stem cells. The expression profile has been
performed by qRT-PCR employing a pooling strategy. Using this
new approach, we were able to analyze the expression of every
single mouse miRNA (miRBase v.12) at different time points
during the differentiation process of murine mesenchymal stem
cells into terminally differentiated adipocytes. The pooling of
samples significantly reduces work load while the sensitivity of a
real-time PCR based approach significantly exceeds other
alternative methods like Northern blot or even miRNA expression
microarrays. Using such a pooling approach we showed that
complex PCR-based miRNA screening projects could be handled
in a reasonable time, even by laboratories devoid of extensive lab
automation. This strategy could also be employed as a primary
screen profiling microRNA expression in different animal tissues
(e.g samples from a variety of brain regions). After the
identification of miRNAs that are expressed in any of the pooled
samples, the tissue-specific expression of these ‘‘primary hits’’ can
be determined by qRT-PCR analysis of the individual samples. In
such a study design, the primary screening serves only for the
qualitative detection, whereas for the quantitative analysis of
microRNA expression, each sample needs to be tested individu-
ally.
Using pooled samples results in the dilution of each individual
sample within the pool, with the consequence of reduced
sensitivity during quantitative PCR analysis. The theoretical loss
of sensitivity can be calculated as follows: given an ideal
amplification efficiency of 100% (E=100%) with a doubling of
the PCR product with each amplification cycle, the slope of a
dilution curve (S) could be calculated as 23.322 using the
following equation: E=(10e(21/S)21)6100. This means that a
ten-fold reduction of template-DNA would result in a 3.322 higher
CT value. By pooling five cDNA samples, as we did in the present
study, the copy number for a specific target cDNA from one
sample is diluted 5-times in the resulting pooled cDNA. Therefore,
the loss of sensitivity for each individual sample in the pool is small,
as the CT value of transcripts present in only one of the five pooled
samples would be 2.322 CT higher than in the individually
analyzed sample. Statistically, an average CT value of 35 means,
that there are about five copies of the miRNA transcript detected
in the PCR reaction [20]. That is why there is no biological
relevance of transcripts detected with CT values .35. According
to that, the limit of detection in pools of 5 samples is lowered to a
CT of 32.7.
A big advantage of the SYBR Green-based miRNA PCR assays
used in this study is the possibility to quickly verify the specificity of
the amplified sequences by studying the melting curves of the
miRNA-specific PCR products. These largely uniform amplicons
should all display very similar Tms of 75uC. In the rare case that
PCR-products with significantly higher melting temperatures were
produced these have been proven to be not specific using agarose
gel-based fragment size determination. There may be a theoretical
risc for cross reactivity between closely related microRNA
isoforms, such as from the let-7 family, not distinguishable by
melting curve analysis alone. Nevertheless, a recent study has
provided evidence for the relatively high specificity of the miRNA
PCR assays employed in our present study [21]. For several
members of the let-7 family, Kumar et al. could demonstrate that
the amplification of related miRNAs was much less efficient than
that of the actually analyzed miRNA. Therefore, these unspecific
amplicons contribute only to a lesser part to the overall signal.
Technically, the pooling of samples for RT-PCR analysis
-besides economical aspects- has several benefits compared to gene
chip technology platforms usually employed for such screening
approaches. Since microarray platforms are less sensitive in the
significance was calculated using student’s t-test. * p,0.05 ; **p,0.01 C: For the diet induced obesity model, miRNA expression in epididymal fat
pads from chow or high fat diet fed wild-type as well as from PPARc DN (P465L) mice was determined by real-time PCR. Five mice were analyzed for
each condition. Data were normalized to SNORA73A expression and plotted as relative expression levels compared to wild-type normally fed mice.
Anova tests revealed significantly regulated miRNAs * p,0.05 ; **p,0.01 and influence of genome (a), diet (b) or interaction of both (c).
doi:10.1371/journal.pone.0021305.g005
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preparations is not recommended. In direct comparison, the
sensitivity of a PCR-based detection with a ‘‘Limit of Detection’’ of
ten copies is 1000-times higher than what could be achieved with
microarrays [20] [22]. The specificity of the hits of such a
microarray analysis could not be easily verified. This in particular
is an important aspect to consider when thinking of the detection
limitations introduced by the short length of the target structures
(mature miRNAs with a length of 21–23 base-pairs). In contrast to
current mRNA expression arrays, where multiple target-specific
probe sets per gene are employed to guarantee specificity, such a
redundant design is not feasible for miRNA microarrays.
miRNA expression profiling of mesenchymal stem cell
derived adipocytes
The murine bone-marrow-derived mesenchymal stem cells used
in this study have the potential to differentiate into adipocytes.
Accumulation of lipid droplets in the cytoplasm of differentiating
cells could be easily used to estimate the percentage of fat cells in
the culture. Such stem cell derived adipocytes are a relevant model
for white fat tissue differentiation and may help to better
understand the underlying differentiation mechanisms and to find
potential therapeutic targets for obesity or metabolic diseases.
Among the 66 miRNAs found in our study to be differentially
regulated in MSC-derived adipocytes, miR-103/107 and miR-143
have already been found to play a crucial role in adipocyte
differentiation [23,24]. The direct involvement of miR-143 in
adipocyte differentiation has been studied by using antisense
oligonucleotides in cultured human pre-adipocytes. In this model,
blocking of miR-143 reduced the expression of adipocyte
differentiation markers by 50% [25]. Opposite effects have been
observed after ectopical expression of miR-143 in 3T3-L1 cells
which led to the up-regulation of adipocyte marker genes [24]. It
has also been reported that elevated expression levels of miR-103
accelerate adipocyte differentiation upon treatment with differen-
tiation factors [24].
The terminal differentiation of mesenchymal stem cells into
mature adipocytes in vitro is a process involving two major steps:
firstly, cells need to be growth arrested, and secondly the treatment
with differentiating agents induces the transformation into adipo-
cytes (reviewed in [17]). In order to be able to distinguish miRNA
expression changes that were rather related to adipocyte differen-
tiation from those that occurred as a result of growth arrest alone,
we analyzed the expression of the 66 candidate miRNAs in growth
arrested mouse fibroblast cell line NIH/3T3, which does not have
the potential to differentiate into adipocytes. Comparing growth
arrested cells to normally dividing control cells, the expression of 8
of the 66 analyzed miRNAs was affected by growth arrest in NIH/
3T3 cells (fold-changes .+/22). Among those, were miR-7a, miR-
7b, miR-146b, miR-199a and miR-199b* that were regulated at
very early time-points after induction of MSCs and show the same
direction of up- or down-regulation in the NIH/3T3 model.
Comparing our data with those obtained with the 3T3-L1
adipogenesis model used by Xie and coworkers further supports
theassumption,thatthesemiRNAsmaynot havea directroleinthe
adipogenic differentiation process [24]. Only miR-146b is found to
be moderately up-regulated,and none of theother seven miRNAsis
significantly changed in this study. A direct involvement of miR-
146b in adipogenesis has not yet been described to our knowledge.
Recently it has been shown that miR-146b expression could
suppress breast cancer metastasis [26], supporting our finding of its
involvement in growth regulation rather than adipogenesis.
Besides the regulation of miR-103/107 and miR-143, we could
also confirm the up-regulation of miR-422b, miR-148a, miR-30c,
and miR30a-5p found in differentiating 3T3-L1 cells by Xie and
colleagues [24]. Nine of the miRNAs we found to be regulated have
also been described by Esau and co-workers in human white
adipocytes [25]. Although differentiated adipocytes have been
compared to pre-adipocytes in this study, the overlap was high.
BesidesmiR-103/107 andmiR-143,miR-30cwasalsoupregulated.
These three miRNAs were the only ones that were consistently
upregulated in our analysis as well as in the work of Esau et al.
(2004) as well as in Xie et al. (2009). In general, the number of
significantly regulated miRNAs we found differentially expressed
was higher compared to the other two studies [24]. One obvious
explanation is the number of miRNAs that were investigated in the
individual studies. Esau and coworkers analyzed differential
expression of 254 human and mouse miRNAs and Xie et al.
(2009) used gene chip arrays based on miRBase version 9 for the
analysis of 375 miRNAs in differentiating 3T3-L1 cells, We have
anlaysed the expression of all mousemiRNAs publishedin miRBase
12, a total of 583 miRNA sequences.
miRNA expression in adipose tissue from obese mice
Studying the miRNA regulation in different in vivo models can
help to strengthen the biological relevance of the findings received
from the in vitro differentiation model employed here. In the
present study, we have used ob/ob mice as a genetic model for
obesity. As a second model, we analyzed fat tissue from mice with
diet-induced obesity. either having a normal genetic background
or harboring a dominant negative mutation of PPARc.
Comparing white fat tissue from obese leptin-deficient ob/ob-
mice with tissue from normally fed wild type mice revealed that
most of the upregulated miRNAs in the differentiated MSC model
were downregulated in fat pads from these obese mice and vice
versa. Only a small number (3/20) of microRNAs were consistently
regulated in both model systems. Similar observations have been
made earlier for adipogenic genes that are normally up-regulated
during adipogenesis, but show reduced expression in epididymal fat
pads of ob/ob mice [27–29]. The reverse regulation of miRNA
expression in white fat tissue of ob/ob-mice compared to
differentiated 3T3-L1 adipocytes has also been reported earlier
[24]. In this study, miRNAs being regulated in white fat of ob/ob-
mice are similarly regulated in TNFa treated differentiated 3T3-L1
adipocytes. As TNFa treatment may induce insulin resistance by
reactivating the expression of preadipocyte genes in vitro [30] [24]
this may be the reason why the majority of miRNAs found in our
study are oppositely regulated in differentiated, insulin-sensitive
adipocytes and insulin resistant ob/ob mice. Alternatively, mature
adipose tissue is quite different in terms of its make up to a simple
adipocyte culture model. Adipose tissue contains multiple cell types
including adipocytes, preadipocytes, stem cells, endothelial cells,
macrophages and multiple other immune cells. The differential
regulation we observed between the MSC culture system and the
effect of obesity on adipose tissue in vivo may reflect the regulation
of miRNAs in non-adipocyte or preadipocyte cell types.
Using our second mouse model of obesity, the influence of a
high fat diet on miRNA expression could be analyzed either
physiologically or under conditions when PPARc activity was
reduced. By comparing lean PPARc wt animals on a chow diet
with obese littermates receiving a high fat diet, normally fed
PPARc DN and PPARc DN mice with diet-induced obesity, we
were able to differentiate effects only induced by diet from those
effects observed as a consequence of reduced PPARc activity and
effects due to an interaction between diet and genotype.
Interestingly, only four of the 21 regulated miRNAs (miR-199a,
miR-455, miR-592, and miR-1192) were solely dependent on the
genotype; independent of diet, the expression of miR-199a, miR-
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whereas miR-592 was down-regulated in these mice compared to
wt. After heterodimerization with the retinoic acid-like receptor
(RXR), PPARc recognizes the peroxisome proliferator response
element (PPRE), that is located in the promoters of many
adipocyte-specific target genes and thereby acts as transcription
activator recruiting other transactivators like PGC-1 [31].
Therefore the diet-independent downregulation of miR-592 in
PPARc DN animals indicates that miR-592 expression is directly
or indirectly (if e.g. co-expressed as an intronic miRNA within the
transcript of a PPARc-responsive host gene) driven by PPARc.A s
miR-199a, miR-455 and miR-1192 were up-regulated in PPARc
DN animals this may indicate that PPARc normally inhibits their
expression directly (e.g. by recruiting transcriptional inhibitors to
those promoters) or indirectly (by the PPARc specific transctiva-
tion of a transcriptional inhibitor).
Eleven of the 21 miRNAs were found to be up-regulated in these
animals upon feeding a high fat diet, irrespective of the PPARc
a c t i v i t y .A m o n gt h o s e ,l e t - 7 i ,m i R - 1 4 6 b ,m i R - 1 5 2 ,m i R - 1 5 5 ,m i R -
214*, miR-299 and miR-411 are similarly regulated in differentiating
MSCs, whereas miR-421, miR-702 and miR-703 were oppositely
regulated in MSCs. According to our statistical analysis, the
regulation of miR-7b, miR27a and miR-34a is influenced by diet
and genotype of the animals together. In PPARc-wt animals,
administration of a high fat diet leads to significantly higher
expression levels compared to lean control animals, whereas
PPARc-dominant negative animals do not show increased expression
levels of these microRNAs when receiving the same high fat diet. This
indicated that PPARc activity is indispensable for the HFD induced
expression of these three miRNAs. In a recent study investigating the
influence of the body mass index (BMI) of obese and lean human
donors on miRNA expression in the subcutaneous fat depot, miR-
34a was found to positively correlate with BMI .30.0 Kg/m
2 [32].
On the other hand the expression levels of miR-34a remains constant
in our leptin-deficient ob/ob mice as well as PPARc-dominant
negative HFD animals in comparison to the respective control group
even though the degree of obesity in these animals is at least
comparable to or in the case of ob/ob mice much higher than in the
group of PPARc-wt HFD mice. These findings suggest that miR-34a
is only up-regulated in obese individuals having a normal genetic
background and with normal levels of PPARc activity.
Overall there were relatively few miRNAs that were similarly
regulated in the ob/ob model and by HFD. This may be because
of the differing degrees of obesity or due to a specific effect of the
lack of leptin in the ob/ob mouse. However, it is important to note
that the dietary-induced obesity model and the ob/ob mouse
model were on different genetic backgrounds (c57/bl6 for the ob/
ob, a mixed C57/bl6/sv129 background for the DIO model).
Genetic background can have significant effects in terms of the
response of mice to HFD [33] and it is possible the different
patterns between DIO and genetic obesity were driven by the
different genetic backgrounds. However, the fact miR702 and
miR155 were co-ordinately regulated in the DIO and genetic
obesity models, despite the differences in genetic background,
provides additional robust evidence for the generality of these
changes in adipose tissue in response to obesity.
We studied the global expression pattern of all known murine
miRNAs during the differentiation process of mesenchymal stem
cells into terminally differentiated adipocytes. In this model
system, we identified a collection of 66 miRNAs with significantly
altered expression. Comparing our findings with similar experi-
mental approaches we could confirm the involvement of certain
miRNAs in the adipogenic differentiation process. Some other
miRNAs have not yet been described before in this context.
Further studies will unveil the relevance of these newly discovered
miRNAs with regard to their suitability to serve as biomarkers or
even therapeutic targets for obesity and obesity-related diseases.
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